This week, the FDA opened applications for its Expedited IND Pilot, quality experts presented at the PDA/FDA Joint Regulatory Conference, and Hovione expanded its spray drying capacity.
|Articles|December 2, 2019
- Pharmaceutical Technology-12-02-2019
- Volume 43
- Issue 12
Triple Shaft Mixer with Powder Induction Manifold
The latest 600-gallon VersaMix Model VM-600 from Ross is qualified for high-speed subsurface powder induction with a proprietary Ross Solids/Liquid Injection Manifold (SLIM).
The latest 600-gallon VersaMix Model VM-600 from Ross is qualified for high-speed subsurface powder induction with a proprietary Ross Solids/Liquid Injection Manifold (SLIM). The SLIM incorporates powder and liquid phases into the rotor-stator mix head, which rotates at 3600 RPM.
Available in laboratory sizes up to 4000 gallons, the mixer uses a dual-post triple-shaft design for the processing of substantial powder phases along with an anchor agitator to move the product from the high shear rotor stator head to a high-speed dispersing head, which deagglomerates any remaining fisheyes. The SLIM feature also enables the device to mix large batches and accelerate loading phases.
Articles in this issue
almost 7 years ago
Applying Lessons Learned from the Semiconductor Industryalmost 7 years ago
Visualization Enhances Facility Designalmost 7 years ago
Bio Diol and IEX Columnsalmost 7 years ago
Two-step Disposable Autoinjectoralmost 7 years ago
Cube Plus for Pharmaceutical Manufacturingalmost 7 years ago
Fighting the Good Fightalmost 7 years ago
Managing Excipient Interactionsalmost 7 years ago
‘Polling’ All the Wayalmost 7 years ago
The Challenges for Regulators in the Digital Agealmost 7 years ago
Tackling Solubility in Drug DevelopmentRelated to this article
Christy Owings, Thermo Fisher, explains clinical trial supply chain risks in Latin America, importer-of-record strategy, AI, and eCOA delays.
PharmTech AI Pulse Check debuts: pharma experts tackle GxP 'slop,' multi-agent validation risk, OCR document mining, personalized mRNA cancer therapy.
Andrea K. Kerrigan, FDA, outlines how validation, data integrity, and QRM determine whether digital tools and AI strengthen or undermine CGMP compliance.
PharmTech spoke with Tara Dougal, event director for pharma at Informa Markets, about trends impacting the pharmaceutical industry and how CPHI Milan is addressing these areas this year.
Andrew Parker, PhD, executive drug development consultant, Quotient Sciences, explains how AI is integrated into pharmaceutical development.
PDA/FDA 2026 session maps the GMP audit lifecycle, root cause to CAPA closure, plus a local vs. above-site decision framework and two case studies.
The recently opened NJ spray drying facility doubles capacity for amorphous solid dispersions, addressing solubility limits in roughly 70% of small-molecule pipelines.